Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)

Stopped early

Conditions studied: Urea Cycle Disorder

In brief

THRIVE is an observational study that will collect information on patients with UCDs. THRIVE will follow enrolled participants for up to 10 years. As an observational study, enrolled patients will not be required to make any additional office visits or take any medicine outside of normal care.

Key facts

Study ID

NCT01948427

Run by

Amgen

People needed

203

Starts

2013-09-25

Expected to finish

2020-02-24

Last updated by the study team

2024-07-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed or suspected diagnosis of UCD
• Signed informed consent/Health Insurance Portability and Accountability Act (HIPAA) Authorization and medical records release

You may not qualify if…

• Any other reason that, in the Investigator's opinion, makes the patient unsuitable to participate in this study.

Where it is running

• United BioSource Corporation — Blue Bell, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.